Our Story

As human and animal health companies struggle to advance medical innovation while managing costs, the outsourcing of research and development functions has become a critical strategy for success. BioResearch Central's CRO concentration fulfills that strategy by providing the outsourcing resource needed to accelerate healthcare innovation.

Our Advantage

The top 16 global pharmaceutical companies have turned to BioResearch Central companies for contract research services. And our CROs have contributed to the development of more than 60 currently marketed pharmaceutical products.

Any research sponsor seeking more targeted and collaborative partnerships that provide consistent quality, efficiency, reliability and the mitigation of risk should consider working with the companies of BioResearch Central.

Our Assets

BioResearch Central employs more than 9,000 people and generates nearly $1 billion in revenue each year. View NDDA Report

Our Companies

BioResearch Central companies represent one of the nation's 15th largest concentrations of contract research organizations and related service providers.

Search our company directory
to locate a specific organization


Download the 2013
CRO Regional Survey Report


Our Region

BioResearch Central is part of a larger regional network of life science assets that strengthen its offerings and advance contract research and its supporting services. The Greater KC region is a proven global leader in drug development, diagnostics, clinical research, and animal health. We are home to 200 life science companies employing more than 20,000 people, and our public and private research spending exceeds $1.8 billion annually.

Learn more about the extensive life science assets within the Greater KC Region:


    World Orphan Drug Congress USA 2015 Location: The Washington Hilton, Washington, D.C For More Information PEGS 2015 Location: